On April 1, 2021 Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, reported that management will participate in 1×1’s at investor conferences through April 2021 (Press release, Autolus, APR 1, 2021, View Source [SID1234577542]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

April 6 and 8, 2021 – Wells Fargo Annual Biotech Corporate Access
April 14, 2021 – 20th Annual Needham Virtual Healthcare Conference – As well as 1×1’s, the CEO and CFO will participate in a Fireside Chat at 10:15 AM ET. A webcast of the Fireside Chat will be available on the investor relations section of the Company’s website at Autolus.
April 22, 2021 – Raymond James Oncology Summit
April 28, 2021 – Kempen & Co. European Life Sciences: Gene, Cell, and RNA Day